1 Free trade agreements – Australia’s experience Sanya Smith Third World Network 25 August 2006 Bangkok.

Slides:



Advertisements
Similar presentations
Impact of JUSFTA on affordability and availability of medicines from perspective of local generic manufacturers Towards equitable and affordable medicine.
Advertisements

FTA USA-Peru and access to medicines Roberto López Linares Acción Internacional para la Salud LAC
Intellectual property rights and procurement = international developments & national experiences = Bi-regional Workshop on procurement and supply management.
Actions Developing in Countries Accessing the WTO System Vung Tau, February 2006 “US – Brazil Compulsory licensing.
Using FTA Side Letters and Congressional Letters to Authorize Waiver of Data Exclusivity and Linkage Professor Brook K. Baker Northeastern U. School of.
Access to medicines – Barriers relating to intellectual property rights and data exclusivity Julian Cockbain & Sigrid Sterckx Yale conference Human rights.
XIX International AIDS Conference July 2012 Washington DC, USA The Brazilian experience: the campaign for access to lopinavir/ritonavir and efavirenz compulsory.
Canada’s Paragraph 6 Legislation: What next? Rachel Kiddell-Monroe Coordinator for Access to Essential Medicines Campaign, MSF Canada.
1 Review of Art 39.3 TRIPS – interpretation and controversy Sanya Smith Third World Network 25 August 2006 Bangkok.
Possible Impact of Market Exclusivity Extension on Pharmaceuticals in Thailand Chutima Akaleephan International Health Policy Program, Thailand 27 August.
Challenges and Opportunities to Utilize TRIPS Flexibilities in Current Ukrainian Legislation: Potential Impact of IP Provisions in the Proposed EU FTA.
Intellectual Property, Free Trade Agreements and sustainable Development Hanan Sboul Secretary General/ The Jordanian Association of Pharmaceutical Manufacturers.
Patents in Indian Fisheries Sector  Patents in Indian Fisheries Sector  Living things generally do not qualify for being granted with patents.  If it.
The use of TRIPS flexibilities to protect health in South Africa and the opportunities for pro-public health reform of national legislation Nokhwezi Hoboyi.
IP News 指導老師:李柏靜 學生:黃馨葦 M /3/26.  Citing the high cost of one of the pharmaceutical industry's expensive new cancer drugs, India's patent.
Map of TPP negotiating countries:
Intellectual Property and Access to Affordable Medicines: TRIPS Plus
A very short introduction to patents & access to medicines.
Linking Intellectual Property Rights to Drug Registration: Practices and Experiences Jose Maria A. Ochave, Esq. Philippine Judicial Academy Seminar on.
TRIPS, Doha and Access to Medicines: Recent Lessons CARSTEN FINK Globalization, Intellectual Property Rights and Social Equity: Challenges and Opportunities.
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN ZAMBIA PROPOSED PATENT BILL AND ITS RELEVANCY.
Cambodian CSOs Advocacy on Legislation Environment Presented by: Mr. Mi Nac Coalition building, Advocacy and Networking Manager, CCC The Law on Associations.
International Max Planck Research School for Competition and Innovation WIPO – Owais Hassan Shaikh IMPRS-CI 2010 Data Exclusivity Provisions.
Data exclusivity, patents and registration of medicines Karin Timmermans TWN Regional Workshop Kuala Lumpur on bilateral trade agreements Aug
Trade Liberalisation. Micro Reform – Trade Liberalisation Trade liberalisation is about removing the barriers that are designed to restrict international.
TRIPS plus FTAs Rohit Malpani Oxfam America. Public health consequences of TRIPS plus FTAs Prospective studies on FTAs with TRIPS plus provisions –US.
The Pharmaceutical Industry in Turkey
1 CUTS International Capacity Building Training Programme on Advance IPR, WTO-Related Issues and Patent Writing April 28-May 02, 2008, Jaipur Session 10.
Australia-US Free Trade Agreement Overview. Outline Bilateral trade strategy US Agenda Australian agenda Community campaign Campaign achievements Campaign.
Ten Years of the Doha Declaration: The State of Implementation Geneva 14 November
© 2008 International Intellectual Property June 22, 2009 Class 6 Patents: Multilateral Agreements (Paris Convention); Economics of International Patent.
Getting the best treatment to the most people possible Enabling policies: threats & opportunities MSF Access Campaign.
World Trade Organization (WTO) accession and implications for public health Sanya Reid Smith Third World Network Kiev 22 September
Unit 12 Notes. What is TRADE? Trade is the voluntary exchange of goods and services among people and countries. Trade and voluntary exchange occur when.
The Doha Declaration and the Protocol amending the TRIPS Agreement Islamabad, 28 November 2007 Octavio Espinosa WIPO.
The cases of Guatemala, El Salvador, Honduras, Nicaragua, Dominican Republic and Costa Rica (in process)
UNCTAD/CD-TFT 1 Exclusive Rights and Public Access – Flexibilities in International Agreements and Development Objectives The Public Health Example 21.
Big Business & Monopolies Page 16 U.S. economy originally based on “Laissez - faire” Means government did not interfere with the economy.
© 2008 International Intellectual Property June 24, 2009 Class 8 Patents: Multilateral Agreements (WTO TRIPS); Global Problem of Patent Protection for.
TRIPS+ provisions in FTAs and the implications for access to medicines Sanya Smith Third World Network 27 August 2005.
The Move to Freer Trade Trade Agreements. A Move to Freer Trade Post-war Re-building (1946). A international financial structure was needed to deal re-building.
UNCTAD/CD-TFT 1 Basic Features of the Multilateral Systems of Patents and Regulatory Test Data Development Dimensions of Intellectual Property Rights Hanoi.
Trade Barriers.
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN ZAMBIA PROPOSED PATENT BILL AND ITS RELEVANCY.
 Government actions that are designed to protect domestic industries and jobs from foreign competition.  While international trade allows people and.
PATENT POOL & its CONCERNS PATENT POOL & its CONCERNS Manmohan A Amonkar 20 July 2010.
The Australian wine industry position on Geographical Indications TONY BATTAGLENE DIRECTOR, INTERNATIONAL & REGULATORY AFFAIRS.
IMPACT OF THE DOHA DECLARATION November 14, 2011 Carlos M. Correa.
‘Linkage’ & other TRIPS+ provisions: a public health perspective Karin Timmermans World Health Organization Seminar “Data exclusivity and patent Bangkok.
Implementation of TRIPS Flexibilities In National IP Legislation For Strengthening Access To Medicines In Swaziland Workshop with MOH and stakeholders,
CHAPTER 7 THE POLOTICAL ECONOMY OF INTERNATIONAL TRADE.
South Africa’s Acceptance of the Protocol Amending the TRIPS Agreement Xolelwa Mlumbi- Peter DDG: ITED 24 November 2015.
Chapter 6 The Theory of Tariffs and Quotas. Copyright © 2005 Pearson Addison-Wesley. All rights reserved. 6-2 Chapter Objectives Introduce the theory.
TRIPS-Plus Pressures: Trade Agreements, and New Trade Policy Prof. Brook K. Baker OSI Kiev – IPRs & A2M, Sept. 16, 2009.
FREE TRADE AGREEMENTS Prathibha Siva Lawyers Collective HIV/AIDS Unit, India East Africa Consultation, September 2010.
Overview: The South African IP Policy Review 13 September 2012 MacDonald Netshitenzhe: Chief Director- Policy and Legislation.
NAFTA, CAFTA and Access to Medicines and Food Security in Latin America International Aids Conference Session “Globalization and FTAs: their impact, access.
TRADE NEGOTIATION ON PHARMACETICALS PRESENTED BY CHOGO,MALESO (092SIS10).
Overview of presentation
Intellectual Property, Free Trade Agreements and sustainable Development Hanan Sboul Secretary General/ The Jordanian Association of Pharmaceutical Manufacturers.
Intellectual Property and Access to Affordable Medicines: TRIPS Plus
International Economics
PATENTS, TRIPS, FLEXIBILITIES & ACCESS TO MEDICINES
Patent law update.
WIPO NATIONAL SEMINAR ON INTELLECTUAL PROPERTY RIGHTS AND THE PROTECTION OF PHARMACEUTICAL PRODUCTS Damascus, April 25 and 26, 2005 Current issues on Intellectual.
Competition and Consumer Act issues affecting franchises
FREE TRADE AREAS.
IPR in FP7 Bart Janse DG Research A.2.
The EU-US Agricultural Framework Agreement
Tariffs and protectionism
Presentation transcript:

1 Free trade agreements – Australia’s experience Sanya Smith Third World Network 25 August 2006 Bangkok

2 Background Australia rejected a US free trade agreement (FTA) twice before finally accepting it Australia is a net intellectual property importer so it was not in its interests to have strong intellectual property protection About 90% of patents granted in Australia are to foreigners Australia did not have and did not want data exclusivity or linkage

3 How Australia got data exclusivity (DE) Australia was forced by Special 301 pressure by the USA to introduce 5 years of DE Australia could have revoked this But then when Australia agreed to a US FTA the DE was locked in In FTA negotiations, USA wanted 8 years of DE Australia only gave 5 years of DE because of public pressure on the Australian Government Now if Australia does not grant 5 years of DE, US can ultimately raise tariffs against any Australian export

4 Impact of DE Before DE, Australian generic manufacturers were using the originator’s data to launch immediately If there was no patent If there was a patent (because they changed the medicine slightly so it did not infringe the patent, but was still the same medicine for the purposes of registration and so could still use the originator’s data to register)  generic competition and cheaper prices from an early stage After DE was introduced, generics had to wait 5 years before they could market their version  prices were higher for longer

5 Linkage between patent status and medicine registration Prior to the USFTA, Australia did not have linkage So if Australia could issue effective compulsory licences The US FTA forced Australia to have linkage

6 Attempts to make linkage less worse Opposition party in Australia tried to implement the USFTA linkage provision in a way that was less bad for public health by passing amendments to domestic implementing legislation While Australian Parliament was considering it, US complained and threatened to stop FTA It was an empty threat, FTA continued After the FTA started, the US continued to press for repeal of the amendments Australian Government was planning to repeal the pro-public health amendments but appears to have given up for the moment due to public outcry

7 Thank you Questions to